Added to YB: 2024-03-21
Pitch date: 2023-12-31
MRVI [bearish]
Maravai LifeSciences Holdings, Inc.
+45.11%
current return
Author Info
No bio for this author
Company Info
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
Market Cap
$527.9M
Pitch Price
$6.54
Price Target
N/A
Dividend
N/A
EV/EBITDA
-12.75
P/E
-4.32
EV/Sales
4.36
Sector
Life Sciences Tools and Services
Category
N/A
ClearBridge Investments Mid Cap Strategy: Exiting Maravai LifeSciences Holdings, Inc.
MRVI - Exited position as COVID-19 revenue declines and supply chain issues persist. Correcting these challenges may take longer than anticipated. Proceeds used to consolidate healthcare exposure in higher-conviction holdings.
Read full article (1 min)